EMA accelerated assessment is similar to FDA’s BTD and priority review. As a result of the AA designation, the CHMP could approve G/P as early as 2H17.
Please chase the links in #msg-127281791 for related info.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.